alendronate has been researched along with Local Neoplasm Recurrence in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Many women now survive breast cancer, but find themselves at increased risk of menopausal complications." | 1.31 | Managing menopause after breast cancer: balancing risks and benefits. ( Moore, HC, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oura, S | 1 |
| Sakurai, T | 1 |
| Yoshimura, G | 1 |
| Tamaki, T | 1 |
| Umemura, T | 1 |
| Kokawa, Y | 1 |
| Moore, HC | 1 |
2 other studies available for alendronate and Local Neoplasm Recurrence
| Article | Year |
|---|---|
[Effective alendronate therapy against a bone metastasis occurring during docetaxel therapy for breast cancer--a case report].
Topics: Aged; Alendronate; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Docetaxel; F | 1999 |
Managing menopause after breast cancer: balancing risks and benefits.
Topics: Adult; Alendronate; Antidepressive Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Calcit | 2001 |